Fernández-Rueda María, Calvo-Henriquez Christian, Fernández-Liesa Rafael, García-Fernández Alfredo, Pedrero-Tomé Roberto, Blázquez-Gamero Daniel, De Vergas Guiterrez Joaquín
Department of Otorhinolaryngology-Head and Neck Surgery, Hospital Universitario 12 Octubre, Avenida Córdoba S/N, 28041, Madrid, Spain.
Department of Otorhinolaryngology-Head and Neck Surgery, Hospital Complex of Santiago de Compostela, Santiago de Compostela, Spain.
Eur Arch Otorhinolaryngol. 2025 Apr;282(4):1659-1676. doi: 10.1007/s00405-024-09013-0. Epub 2024 Oct 4.
To search for existing evidence of prognostic factors related to the development of late-onset hearing loss (LOHL) in infants with congenital cytomegalovirus (cCMV).
A PRISMA systematic review was performed, with the PubMed, Embase, and Web of Science databases searched from inception through to December 2023; after the application of inclusion and exclusion criteria a total of 9 papers were included in this review. PROSPERO registration number CRD42024492244.
9 studies encompassing a total of 292 children with late-onset hearing loss were included. A total of 12 risk factors were identified in the literature, with 6 found to be statistically significant. Late-onset hearing loss was more frequently reported in children with symptomatic than asymptomatic cCMV. Moreover, in asymptomatic cCMV cases, elevated DNAemia and salivary viral load were associated with late-onset hearing loss. Additionally, first-trimester seroconversion was identified as a risk factor for late- onset hearing loss. Further, gestational age < 37 weeks and low birth weight were found to correlate with late-onset hearing loss. Remarkably, only one study documented a relationship between late-onset hearing loss and ultrasonographic abnormalities.
Although six statistically significant risk factors have been identified, the available evidence is limited and inconsistent, preventing the establishment of reliable neonatal and maternal parameters to predict the development of LOHL in patients with CMV. There are few studies addressing this topic, and those available exhibit a low level of evidence and heterogeneous designs. More studies should be done.
寻找与先天性巨细胞病毒(cCMV)感染婴儿迟发性听力损失(LOHL)发生相关的预后因素的现有证据。
进行了一项PRISMA系统评价,检索了从数据库建立至2023年12月的PubMed、Embase和Web of Science数据库;在应用纳入和排除标准后,本评价共纳入9篇论文。PROSPERO注册号为CRD42024492244。
纳入了9项研究,共292例迟发性听力损失儿童。文献中共确定了12个危险因素,其中6个具有统计学意义。有症状的cCMV感染儿童比无症状的儿童更常报告迟发性听力损失。此外,在无症状的cCMV病例中,血中DNA水平升高和唾液病毒载量与迟发性听力损失有关。此外,孕早期血清学转换被确定为迟发性听力损失的一个危险因素。此外,发现胎龄<37周和低出生体重与迟发性听力损失相关。值得注意的是,只有一项研究记录了迟发性听力损失与超声异常之间的关系。
虽然已确定了6个具有统计学意义的危险因素,但现有证据有限且不一致,无法建立可靠的新生儿和母体参数来预测CMV感染患者LOHL的发生。针对这一主题的研究很少,现有研究证据水平低且设计多样。需要进行更多的研究。